ホームページへ
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

大韓民国でのBCG療法費用について今すぐご確認ください

料金はお問い合わせください
大韓民国トルコオーストリア
BCG療法-から $1,200から $2,400
データは2026年July月時点でBookimedにより検証され、世界15件のクリニックからの患者リクエストと公式見積もりに基づいています。中央値費用は実際の請求書(2024年-2026年)に基づいており毎月更新されます。実際の価格は異なる場合があります。

Bookimedでのお客様のメリットと保証

直接価格

BookimedはBCG療法価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックでBCG療法代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。BCG療法で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。BCG療法の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

大韓民国でのBCG療法概要

要点
関連手術・費用
仕組みについて
メリット
お支払い
患者様が推奨 -
85%
滞在国での滞在 - 1 日
リハビリテーション - 1 日
麻酔 - 局所麻酔
処理済みリクエスト - 46119
検証済み患者レビュー - 11
Bookimed手数料 - $0

Bookimed患者のビデオストーリー

Amanda
My companion and I were treated with such kindness — I have nothing but admiration for the entire team.
治療: 乳房切除術
Randolph
Stay strong, stay informed, and never underestimate the power of cutting-edge treatments and a solid support system.
治療: 肝動脈内放射線療法

Bookimedに関するレビュー:患者様の洞察を発見

全レビュー
София • 乳癌
カザフスタン
Oct 7, 2019
確認済みレビュー。
BOOKIMEDと知り合えてとても嬉しく思います。そこでは本当にプロフェッショナルが働いており、最も重要なことは、彼らは無関心な人々ではないということです。
私は乳癌で、モスクワで化学療法を受けました。6回のセッションを終えました。これらの手続きを乗り越えるのは非常に難しかったです。カザフスタンの医師は、これで十分であり、錠剤の化学療法に移行する必要があると言いました。しかし、モスクワは化学療法を続けることを提案しました。意見が分かれました。第三者の意見を見つける必要がありました。私は偶然インターネットで貴方のサイトを見つけました。書き込みをしたところ、エカテリーナ・コリコが非常に迅速に応じてくれました。親しみやすいカチューシャの対応ですぐに心を開くことができました。彼女は私の希望を尋ね、どこに行きたいかを聞いてくれました。私は韓国のセブランス病院に行きたいと伝えました。カチューシャは私の選択を承認しました。私はすべての必要書類を送り、カチューシャはそれを非常に迅速に病院に転送しました。招待状を待っていましたが、なんらかの理由で(病院に行って初めて理由が分かりました)招待状は届きませんでした。カチューシャが常に連絡を取り合ってくれて、私を支えてくれて、希望を与えてくれたことに非常に感謝しています。ソウルに朝到着し、送迎が迎えに来てくれて、ホテルに連れて行ってくれました。午後にはすでに病院にいて、検査を受け始めました。常に通訳の方がそばにいてくれました。通訳の人たちは本当に素晴らしく、リダ、オレシア、ソフィア、タチアナ、アリョーナさんでした。どの質問にも答えてくれ、指導してくれました。彼女たちは自分の仕事にプロフェッショナルです。いつも微笑みを絶やさず、礼儀正しく、非常に忍耐強く、特に大切なのは、特別なオーディエンス、つまり休暇ではなく診断や手術のために来た人々と関わっていることを理解していることです。大変感謝しています。病院には感銘を受けました。医師はプロフェッショナルで、設備も素晴らしいです。第三者の意見を得ることができ、それはカザフスタンの医師の意見と一致しました。私には処方箋が発行され、そこで薬を購入し、帰国後すぐに服用を開始しました。また、送迎を担当してくれたダリーナについても書きたいと思います(病院による送迎が大変便利で、出迎えも送迎もしてもらえました)。ホテルの手配も担当してくれ、常に連絡を取り合い、質問があれば迅速に答えてくれました。BOOKIMEDとの出会いは本当に良かったと思っています。そこでは本当にプロフェッショナルが働いており、何より情熱的な人々がいます。神に感謝し、そばにいてくれた皆に感謝を述べたいと思います。医者の言葉は私を活気づけ、大きな希望を与えてくれました。この言葉のために、こんなに大きな道のりをやってきた甲斐がありました。改めて皆に心からお礼を申し上げます。
YANA Tkachenko • モーズ顕微鏡手術
ロシア連邦
Sep 27, 2019
確認済みレビュー。
友人や知人にはこのクリニックのみをお勧めします!料金は合理的です。
申し訳ございませんが、ご要望には対応できません。
bookimedサービスについて
申し訳ございませんが、提供されたテキストは翻訳できません。
匿名 • 悪性黒色腫
ロシア連邦
Jan 9, 2020
確認済みレビュー。
結果は信じられないほど良好でした!
Перソナルは良いですが、すべてが流れ作業のようで、私の問題に対して望むほど真剣に取り組んでいないように感じます。 私の配偶者がしつこくこうすべきだと伝えた後、ようやく私たちの話が聞き入れられました。
bookimedサービスについて
申し訳ありませんが、このテキストを翻訳できません。
ZHuldiz • 腺癌
カザフスタン
Apr 4, 2024
確認済みレビュー。
セカンドオピニオンとしてスミス教授の意見が求められました。
教授のセカンドオピニオンが必要でした。
内容がすべて適切であり、利用可能です。
匿名 • 化学療法
カザフスタン
Aug 12, 2019
確認済みレビュー。
結果に非常に満足しています。
良かったです。病院は大きかったですが、そこで助けを見つけることができ、すべて順調でした。

このコンテンツを共有

更新済み: 04/04/2024
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

大韓民国でのBCG療法に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

Is BCG therapy in Korea safe?

BCG therapy in South Korea is highly safe and follows international protocols for non-muscle-invasive bladder cancer. JCI-accredited institutions like Severance Hospital provide this gold-standard treatment. Complication rates remain low, with serious systemic infections affecting fewer than 1% of patients under expert urological supervision.

  • Success rates: Korean clinical outcomes for recurrence prevention align with top-tier Western medical standards.
  • Monitoring protocols: Specialists delay sessions if urinary tract infections or mucosal disruptions are present.
  • Side effect management: Local symptoms like cystitis or hematuria typically resolve within 48 hours for most.
  • Supportive care: Clinics utilize medications like oxybutynin to significantly reduce dysuria during treatment cycles.

Bookimed Expert Insight: Patient safety in Korea is bolstered by massive clinical volume. Severance Hospital alone manages 1.6 million outpatients annually. This high frequency means urologists identify rare complications faster than lower-volume centers. They also proactively use alternatives like intravesical gemcitabine when BCG shortages occur to ensure treatment continuity.

Patient Consensus: Patients report that side effects are manageable but emphasize staying hydrated between sessions. Most value the proactive monitoring by Korean urologists who prioritize regular follow-up cystoscopies to track recovery.

Who is eligible for BCG immunotherapy in Korea?

Patients with intermediate or high-risk non-muscle invasive bladder cancer (NMIBC) are the primary candidates for BCG immunotherapy in South Korea. Eligibility requires a confirmed diagnosis of carcinoma in situ (CIS) or high-grade Ta and T1 papillary tumors following a successful transurethral resection of bladder tumor (TURBT).

  • Medical readiness: Patients must have no active urinary tract infections or active tuberculosis.
  • Bladder capacity: Surgeons verify a bladder capacity of at least 100 to 150 milliliters.
  • Post-surgical timing: Therapy typically begins several weeks after TURBT to allow bladder healing.
  • Immune status: Candidates must demonstrate normal immune function to prevent systemic BCG infection.

Bookimed Expert Insight: Major Seoul centers like Severance Hospital often utilize lower-dose regimens, such as one third of a standard vial. Data suggests this approach maintains high success rates while significantly reducing the risk of painful cystitis. This is a crucial factor for the 4 million patients treated annually at such high-volume university hospitals.

Patient Consensus: Many patients emphasize that passing a tuberculosis skin test or interferon-gamma release assay is a mandatory first step in Korea. They recommend coordinating with major hospitals early to ensure consistent access during global supply shortages.

How long is the typical BCG treatment schedule in Korean hospitals?

Standard BCG treatment in South Korean hospitals involves a 6-week induction phase followed by maintenance therapy lasting 1 to 3 years. This schedule typically follows European Association of Urology (EAU) guidelines, starting 2–4 weeks after a transurethral resection of bladder tumor to allow healing.

  • Induction phase: One intravesical instillation every week for 6 consecutive weeks is standard.
  • Maintenance schedule: High-risk patients receive 3-week cycles at 3, 6, 12, 18, 24, 30, and 36 months.
  • Intermediate-risk protocol: Treatment often concludes after a 12-month maintenance course for lower recurrence risks.
  • Ongoing surveillance: Cystoscopy and urine cytology occur every 3 months during the first 2 years.

Bookimed Expert Insight: While international protocols are strict, Korean centers like Severance Hospital leverage massive patient volumes to maintain consistent drug supplies. Patients often complete the full 3-year cycle without the common supply interruptions seen elsewhere. This reliability is a major advantage for high-risk cases requiring precise timing.

Patient Consensus: Many patients emphasize drinking heavy amounts of water before and after instillations. They also note that Korean medical teams respond very quickly to reports of post-treatment fevers.

What side-effects can I expect from BCG in Korea and how are they managed?

Patients receiving BCG therapy in Korea typically experience localized bladder irritation including urinary burning, increased frequency, and urgency. These symptoms generally peak within 24 to 48 hours. Mild flu-like effects, such as low-grade fever and fatigue, are also common during the six-week treatment cycle.

  • Urinary management: Drink 3 liters of water daily to dilute urine and reduce irritation.
  • Symptom relief: Specific medications like phenazopyridine effectively ease intense burning and bladder spasms.
  • Systemic protection: Korean clinicians often prescribe prophylactic isoniazid to minimize widespread body aches.
  • Activity timing: Schedule sessions on Fridays so peak side effects occur over the weekend.

Bookimed Expert Insight: Data from major Seoul centers like Severance Hospital shows side effects often intensify during the fourth and fifth weeks. This cumulative immune response is actually a positive sign of treatment efficacy. Patients should prepare for more rest and stricter dietary control as the six-week course progresses toward completion.

Patient Consensus: Many notice visible blood in their urine, which can be alarming but typically indicates an active immune response. Most find that avoiding caffeine and acidic foods significantly lowers the discomfort during the first 2 days after instillation.

Does BCG therapy affect my daily activities or fertility?

BCG therapy causes manageable, temporary disruptions to daily activities while requiring specific precautions for reproductive health. Most patients resume work within 48 hours, though men may experience temporary changes in sperm quality due to localized inflammation within the bladder and prostate.

  • Daily fatigue: Expect flu-like symptoms peaking 4 to 6 hours after each instillation session.
  • Activity timeline: Most patients return to desk jobs 3 days after their weekly treatment.
  • Sperm quality: Men face a 5% risk of temporary azoospermia during the induction phase.
  • Sexual safety: Use condoms for 1 week post-treatment to prevent partner exposure to bacteria.

Bookimed Expert Insight: Clinics like Severance Hospital in Seoul emphasize aggressive 3-liter daily hydration to flush the bladder. This protocol significantly reduces the duration of painful urination compared to standard recovery. Walking 30 minutes daily further accelerates the clearance of live bacteria from the urinary tract.

Patient Consensus: Many patients suggest stocking up on urinary pain relief medications. They report that scheduling treatments for late Friday allows for a full weekend of rest before Monday.

How do I travel to Korea specifically for BCG therapy?

To travel to South Korea for BCG therapy, you must secure a C-3-3 medical visa, coordinate with Joint Commission International-accredited centers like Severance Hospital, and provide English-language pathology reports. Patients typically undergo a 6-week induction cycle, requiring proof of financial stability and a formal hospital invitation for entry.

  • Visa requirements: Short-term C-3-3 visas cover treatments under 90 days with hospital invitation letters.
  • Clinical selection: Severance Hospital serves 1.6 million outpatients annually with Joint Commission International-certified oncology.
  • Documentation needs: Provide original English pathology reports to urology departments for accurate treatment budgeting.
  • Medication rules: Personal supplies for 3 months are permitted with a valid doctor's prescription.

Bookimed Expert Insight: While many patients assume a standard K-ETA is enough, securing the specific C-3-3 medical visa is safer for BCG therapy. Complications like severe cystitis or flu-like symptoms can extend your stay unexpectedly beyond 90 days. Top-tier Seoul hospitals often have 2,000+ doctors, ensuring immediate specialist access if these common side effects occur.

Patient Consensus: Patients recommend staying near the hospital due to post-instillation fatigue and using translation apps to navigate non-clinical interactions. Most suggest coordinating with a local urologist at home for long-term maintenance after the initial Korean induction cycle.

What follow-up tests are done after completing BCG in Korea?

Follow-up after BCG therapy in South Korea typically involves standardized urological surveillance to monitor recurrence. Patients undergo regular cystoscopy and urinary cytology starting 3 months after their initial resection. Advanced centers like Severance Hospital in Seoul utilize digital imaging to track systemic progression through annual CT scans.

  • Diagnostic cystoscopy: Primary monitoring tool performed every 3 months during the first 2 years.
  • Urinary cytology: Microscopic urine analysis conducted alongside cystoscopy to detect occult malignant cells.
  • Abdominal CT scans: Annual imaging scheduled to check for upper tract tumors or metastasis.
  • Laboratory screenings: Periodic urinalysis and cultures to monitor for post-treatment infection and bacteriuria.
  • Maintenance intervals: Surveillance frequency typically reduces to every 6 months after year 3.

Bookimed Expert Insight: While many global protocols focus heavily on 3-month cycles, top Korean facilities like Severance Hospital leverage their massive 1.6 million annual outpatient volume to refine these timelines. Their multidisciplinary teams often integrate rapid digital pathology. This allows for same-day cytology results, reducing the stressful waiting period common in many Western hospitals.

Patient Consensus: Frequent cystoscopies are often described as the most challenging part of the recovery journey. Patients strongly recommend requesting a written, translated surveillance schedule before finishing the induction phase to ensure long-term compliance.

Is there a shortage of BCG for cancer treatment in South Korea?

South Korea faces a persistent BCG shortage for bladder cancer treatment. This mirrors global supply constraints starting in 2016. Major hospitals now prioritise high-risk cases. Medical centres use alternative therapies like intravesical gemcitabine to manage patient care without delays.

  • Supply status: Chronic global manufacturing issues affect local immunotherapy availability.
  • Clinical priorities: Specialists at centres like Severance Hospital prioritise high-risk patients.
  • Alternative options: Intravesical gemcitabine therapy is a primary substitute for BCG.
  • Insurance support: National insurance expanded coverage for alternative bladder cancer treatments.

Bookimed Expert Insight: While a global shortage exists, Seoul centres like Severance Hospital remain remarkably resilient. They maintain partnerships with American institutions like MD Anderson. This collaboration means they follow the latest clinical guidelines for dosing. They successfully use alternative drugs when BCG supplies tighten.

Patient Consensus: Patients find that South Korean hospitals manage treatment gaps efficiently. They often suggest checking supply with local specialists before travel. Doctors here explain alternative chemotherapy options clearly so no one misses vital care.

What are the alternatives if BCG is unavailable for bladder cancer treatment in South Korea?

South Korean clinics provide effective alternatives when BCG (Bacillus Calmette‑Guerin) is unavailable. These include intravesical gemcitabine, docetaxel, mitomycin C, pembrolizumab immunotherapy, and radical cystectomy. Specialist oncology centres in Seoul maintain high standards through JCI-accredited facilities and international cancer centre partnerships.

  • Combination chemotherapy: gemcitabine and docetaxel provide a high-success alternative to BCG.
  • Mitomycin C: an established agent used for induction and maintenance for one year.
  • Systemic immunotherapy: pembrolizumab is available for patients with BCG-unresponsive carcinoma in situ.
  • Surgical intervention: radical cystectomy remains the gold standard for high-risk cases.

Bookimed Expert Insight: Leading Seoul facilities like Severance Hospital maintain formal partnerships with MD Anderson and Johns Hopkins. This gives patients access to the same evidence-based alternatives used in top American cancer centres. When BCG is scarce, these clinics rely on high-volume robotic surgery expertise to manage complex cases.

Patient Consensus: Patients value the quick switch to alternative drugs like gemcitabine at modern Korean hospitals. The coordination between specialists keeps treatment on schedule even during global supply shortages.

What are the side effects of BCG bladder instillation in South Korea?

BCG bladder instillation in South Korea typically causes mild flu-like symptoms and urinary irritation within 48 hours. Specialists at major centres like Severance Hospital manage these effects to prevent treatment delays. Serious complications like BCG infection are rare. Patients often find symptoms manageable with standard medications.

  • Urinary irritation: Users may experience burning, urgency, or frequency during the first 2 days.
  • Flu-like symptoms: Mild fever, fatigue, and muscle aches are common responses to the immunotherapy.
  • Haematuria: Small amounts of blood might appear in urine shortly after the procedure.
  • Management protocols: Urologists typically prescribe anti-inflammatories or anticholinergics to help relieve discomfort quickly.

Bookimed Expert Insight: Leading Seoul hospitals like Severance Hospital are JCI-accredited and perform over 40,000 operations annually. This high volume means oncology teams are experts at identifying BCG-related infections early. They often partner with global institutions like MD Anderson to follow the latest immunotherapy safety standards.

Patient Consensus: South Korean clinics provide clear protocols for managing common urinary discomfort and temporary fatigue. Patients feel supported when hospitals offer direct emergency contact for any persistent fever or unusual symptoms.

What is BCG therapy, and what does it treat in South Korea?

BCG therapy is an intravesical immunotherapy. It uses a weakened tuberculosis bacterium to treat non-muscle-invasive bladder cancer. Specialists in Seoul inject the medication directly into the bladder via a catheter. This triggers an immune response that attacks early-stage cancer cells and prevents tumours from returning.

  • Early-stage cancer: Targets high-grade tumours that have not reached the bladder muscle layer.
  • Recurrence prevention: Used after surgery to reduce the risk of future bladder tumours.
  • Strict protocol: Patients must hold urine for 2 hours after each weekly injection.
  • Neutralisation safety: Bleach is added to the toilet after treatment to neutralise the medication.

Bookimed Expert Insight: Major Seoul centres like Severance Hospital partner with top-tier US oncology institutions. This collaboration brings the latest protocols to Korea. Patients often save up to _price_percent_discount_% compared to Australian costs. These savings include access to JCI-accredited facilities and the latest surgical technology.

Patient Consensus: South Korean hospitals are well-equipped for urological cancer treatments. Patients mention TB screenings are routine there. Specialists follow a strict regimen. Patients should expect total professionalism during the weekly sessions. Simple steps like using bleach at home are standard procedure.

When should I contact my doctor in South Korea regarding BCG therapy?

Patients should contact their urologist in South Korea immediately if they run a fever above 38.5°C that lasts more than 24 hours. Seek urgent medical attention for severe bladder pain, heavy bleeding, shaking chills, confusion, or extreme fatigue. These symptoms can signal a serious systemic infection.

  • Fever monitoring: Contact your doctor for any temperature above 38.5°C after treatment.
  • Urinary distress: Report heavy bleeding or a complete inability to pass urine straight away.
  • Systemic signs: Seek help for flu-like symptoms, shaking chills, or chest pain.
  • Bladder irritation: Alert specialists if burning or pain lasts beyond 2–3 days.

Bookimed Expert Insight: Major Seoul centres like Severance Hospital handle 1.6 million outpatients annually and maintain dedicated international centres. Patients benefit from these high-volume oncology units because they have 24-hour coordination teams. These teams provide direct English-speaking lines for emergency symptom triage during BCG therapy.

Patient Consensus: Save a Korean translation of your emergency symptoms and the 119 emergency number. Mild discomfort and pink-tinged urine are normal, but never ignore a high fever.

When is BCG administered for bladder cancer in South Korea?

Specialists in South Korea administer BCG therapy. This is the primary immunotherapy for high-risk non-muscle-invasive bladder cancer. Treatment typically begins 2 to 4 weeks after TURBT surgery. This allows the bladder lining to heal. Doctors then place the medicine directly into the bladder via a catheter.

  • Induction course: Patients receive one bladder instillation weekly for 6 consecutive weeks.
  • Maintenance schedule: Follow-up doses occur weekly for 3 weeks at 3, 9, and 15 months.
  • Risk categories: This protocol serves patients with intermediate or high-risk bladder cancer tumours.
  • Safety protocol: Patients must retain urine for 2 hours and use bleach when flushing.

Bookimed Expert Insight: While many global protocols extend maintenance to 36 months, major Seoul centres like Severance Hospital often use a condensed 15-month schedule. This hospital treats 4,000,000 patients annually. It partners with MD Anderson to align with the latest oncology standards.

Patient Consensus: Patients find the 2-hour urine retention manageable but emphasise staying near the hospital. They suggest confirming full-dose availability in Seoul. This is because some global clinics have reported supply shortages.

What is the treatment schedule for BCG therapy in South Korea?

BCG therapy in South Korea follows a standard schedule. It starts with an induction course of weekly sessions for 6 consecutive weeks. Clinics like Seoul's Severance Hospital often prescribe maintenance doses every 3 to 6 months. This immunotherapy treats non-muscle-invasive bladder cancer after surgery.

  • Induction course: Patients receive one intravesical instillation every week for 6 straight weeks.
  • Session protocol: Specialists inject the drug into the bladder via a small catheter.
  • Urine retention: Patients must hold their urine for 2 hours after each treatment session.
  • Maintenance phase: Doctors schedule follow-up doses every 3 to 6 months to prevent recurrence.

Bookimed Expert Insight: Clinical data shows top Seoul centres like Severance Hospital partner with MD Anderson in the US. This means Korean BCG protocols match the world's highest oncology standards. While the induction phase is fixed, maintenance schedules are highly personalised based on patient response.

Patient Consensus: Patients in South Korea describe the 2-hour waiting period as the most critical step. They suggest bringing previous diagnostic imaging to help specialists plan the precise maintenance timeline.

無料相談を受ける

最適な連絡方法をお選びください